Award recordCONTRACT

SOFIE CO.

PIID 36C24523P0181· VHA· 245-NETWORK CONTRACT OFFICE 5 (36C245)· 6505 · DRUGS AND BIOLOGICALS· FY2023· $1,198,895 net obligations· UEI JV1AHJHGUGG3· VA

Description

THIS IS FOR DEOB MODIFICATION EXPIRED FY23 CONTRACT AND PO PYLARIFY.

Base award description: THIS IS FOR THE PURCHASE AND DELIVERY OF PYLARIFY REQUIREMENT FOR 1 YEAR.

First action · last action
2022-12-29 · 2024-04-08
Transactions
3
First transaction's obligation
$1,082,616
Base + all options value (sum of deltas)
$1,198,895
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,335,226$0Base award · 2022-12-29 · this action $1,082,616 · running total $1,082,616Modification P00001 · 2023-09-15 · this action $252,610 · running total $1,335,226Modification P00002 · 2024-04-08 · this action -$136,331 · running total $1,198,895
  • Base2022-12-29+$1,082,616= $1,082,616
  • Mod P000012023-09-15+$252,610= $1,335,226
  • Mod P000022024-04-08-$136,331= $1,198,895
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-12-29+$1,082,616$1,082,616THIS IS FOR THE PURCHASE AND DELIVERY OF PYLARIFY REQUIREMENT FOR 1 YEAR.
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-09-15+$252,610$1,335,226THIS IS FOR THE PURCHASE AND DELIVERY OF PYLARIFY OF 70 ADDITIONAL PATIENT DOSES.
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-04-08−$136,331$1,198,895THIS IS FOR DEOB MODIFICATION EXPIRED FY23 CONTRACT AND PO PYLARIFY.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JV1AHJHGUGG3)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0392255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$357,066FY2026
36C25526N0245255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,172,834FY2026
36C24226N0463242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$624,017FY2026
36C24226N0388242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$830,796FY2026
36C24226D0040242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C25026P0310250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$347,000FY2026

Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24526N0840TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$19,139FY2026
36C24526N0839TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$38,360FY2026
36C24526N0837QOL MEDICAL LLC245-NETWORK CONTRACT OFFICE 5 (36C245)$16,945FY2026
36C24526N0835TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$34,605FY2026
36C24526N0834GALDERMA LABORATORIES, L.P.245-NETWORK CONTRACT OFFICE 5 (36C245)$16,960FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24523P0181_3600_-NONE-_-NONE- · retrieved 2026-09-26.